Alterations of microRNAs and their targets are associated with acquired resistance of MCF-7 breast cancer cells to cisplatin

International Journal of Cancer

Volumn 127, Issue 8, 2010, Pages 1785-1794

  Pogribny, Igor P ^a   Filkowski, Jody N ^b   Tryndyak, Volodymyr P ^a   Golubov, Andrey ^b   Shpyleva, Svitlana I ^a,c   Kovalchuk, Olga ^b  

^a NATIONAL CENTER FOR TOXICOLOGICAL RESEARCH   (United States)

^b UNIVERSITY OF LETHBRIDGE   (Canada)

^c R E KAVETSKY INSTITUTE OF EXPERIMENTAL PATHOLOGY   (Ukraine)

Author keywords

breast cancer; cisplatin; drug resistance; metastasis; microRNA; miR 345; miR 7

Indexed keywords

CISPLATIN; MICRORNA; MULTIDRUG RESISTANCE PROTEIN 1; ANTINEOPLASTIC AGENT; LUCIFERASE; MESSENGER RNA; MULTIDRUG RESISTANCE PROTEIN; MULTIDRUG RESISTANCE-ASSOCIATED PROTEIN 1; TUMOR MARKER;

3' UNTRANSLATED REGION; ARTICLE; BREAST ADENOCARCINOMA; BREAST CANCER; CANCER CELL; CANCER INVASION; CANCER RESISTANCE; CELL STRAIN MCF 7; CELL SURVIVAL; CONTROLLED STUDY; DNA METHYLATION; DOWN REGULATION; DRUG TARGETING; FEMALE; GENE EXPRESSION; GENE MUTATION; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; METASTASIS; NUCLEOTIDE SEQUENCE; PHENOTYPE; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; UPREGULATION; BREAST TUMOR; DNA MICROARRAY; DRUG RESISTANCE; GENE EXPRESSION PROFILING; GENETICS; METABOLISM; PATHOLOGY; PHYSIOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR CELL CULTURE; WESTERN BLOTTING;

ANTINEOPLASTIC AGENTS; BLOTTING, WESTERN; BREAST NEOPLASMS; CISPLATIN; DRUG RESISTANCE, NEOPLASM; FEMALE; GENE EXPRESSION PROFILING; HUMANS; LUCIFERASES; MICRORNAS; MULTIDRUG RESISTANCE-ASSOCIATED PROTEINS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TUMOR CELLS, CULTURED; TUMOR MARKERS, BIOLOGICAL;

EID: 77956995581     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.25191     Document Type: Article

References (44)

1. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Murray T, Thun MJ,. Cancer statistics, 2008. CA Cancer J Clin 2008; 58: 71-96.
2. O'Driscoll L, Clynes M,. Biomarkers and multiple drug resistance in breast cancer. Current Cancer Drug Targets 2006; 6: 365-84.
3. Longley DB, Johnston PG,. Molecular mechanisms of drug resistance. J Pathol 2005; 205: 275-92.
4. Gonzalez-Angulo AM, Morales-Vasquez F, Hortobagyi GN,. Overview of resistance to systemic therapy in patients with breast cancer. Adv Exp Med Biol 2007; 608: 1-22.
5. Raguz S, Yague E,. Resistance to chemotherapy: new treatments and novel insights into an old problem. Br J Cancer 2008; 99: 387-91.
6. Coley HM,. Mechanisms and strategies to overcome chemotherapy resistance in metastatic breast cancer. Cancer Treat Rev 2008; 34: 378-90.
7. Fojo T,. Multiple paths to a drug resistance phenotype: mutations, translocations, deletions and amplification of coding genes or promoter regions, epigenetic changes and microRNAs. Drug Resist Update 2007; 10: 59-67.
8. Blower PE, Chung JH, Verducci JS, Lin S, Park JK, Dai Z, Liu CG, Schmittgen TD, Reinhold WC, Croce CM, Weinstein JN, Sadee W,. MicroRNAs modulate the chemosensitivity of tumor cells. Mol Cancer Ther 2008; 7: 1-9.
9. Acharya CR, Hsu DS, Anders CK, Anguiano A, Salter KH, Walters KS, Redman RC, Tuchman SA, Moylan CA, Mukherjee S, Barry WT, Dressman HK, et al. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer. JAMA 2008; 299: 1574-87.
10. Kovalchuk O, Filkowski J, Meservy J, Ilnytskyy Y, Tryndyak VP, Chekhun VF, Pogribny IP,. Involvement of microRNA-451 in resistance of the MCF-7 breast cancer cells to chemotherapeutic drug doxorubicin. Mol Cancer Ther 2008; 7: 2152-9.
11. Miller TE, Ghoshal K, Ramaswamy B, Roy S, Datta J, Shapiro CL, Jacob S, Majumder S,. MicroRNA-221/222 confers tamoxifen resistance in breast cancer by targeting p27Kip1. J Biol Chem 2008; 283: 29897-903.
12. Ma L, Teruya-Feldstein J, Weinberg RA,. Tumour invasion and metastasis initiated by microRNA-10b in breast cancer. Nature 2007; 449: 682-8.
13. Negrini M, Calin GA,. Breast cancer metastasis: a microRNA story. Breast Cancer Res 2008; 10: 203.
14. Liang Y, McDonnell S, Clynes M,. Examining the relationship between cancer invasion/metastasis and drug resistance. Curr Cancer Drug Targets 2002; 2: 257-7.
15. Kelland L,. The resurgence of platinum-based cancer chemotherapy. Nat Rev 2007; 7: 573-84.
16. Thomadaki H, Scorilas A,. Breast cancer cells response to the antineoplastic agents cisplatin, carboplatin, and doxorubicin at the mRNA expression levels of distinct apoptosis-related genes, including the new member. BCL2L12. Ann N Y Acad Sci 2007; 1095: 35-44.
17. Thomadaki H, Scorilas A,. Molecular profile of breast versus ovarian cancer cells in response to treatment with the anticancer drugs cisplatin, carboplatin, doxorubicin, etoposide and taxol. Biol Chem 2008; 389: 1427-34.
18. Chekhun VF, Lukyanova NY, Kovalchuk O, Tryndyak VP, Pogribny IP,. Epigenetic profiling of multidrug-resistant human MCF-7 breast adenocarcinoma cells reveals novel hyper-and hypomethylated targets. Mol Cancer Ther 2007; 6: 1089-98.
19. Bolstad BM, Irizarry RA, Astrand M, Speed TP,. A comparison of normalization methods for high density oligonucleotide array data based on variance and bias. Bioinformatics 2003; 19: 185-93.
20. Eisen MB, Spellman PT, Brown PO, Botstein D,. Cluster analysis and display of genome-wide expression patterns. Proc Natl Acad Sci USA 1998; 95: 14863-8.
21. Livak KJ, Schmittgen TD,. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 2001; 25: 402-8.
22. Tryndyak VP, Kovalchuk O, Pogribny IP,. Loss of DNA methylation and histone H4 lysine 20 trimethylation in human breast cancer cells is associated with aberrant expression of DNA methyltransferase 1. Suv420h2 histone methyltransferase and methyl-binding proteins. Cancer Biol Ther 2006; 5: 65-70.
23. Pogribny I, Yi P, James SJ,. A sensitive new method for rapid detection of abnormal methylation patterns in global DNA and within CpG islands. Biochem Biophys Res Commun 1999; 262: 624-8.
24. Siddik ZH,. Biochemical and molecular mechanisms of cisplatin resistance. Cancer Treat Res 2002; 112: 263-84.
25. Siddik ZH,. Cisplatin: mode of cytotoxic action and molecular basis of resistance. Oncogene 2003; 22: 7265-79.
26. Zhao JJ, Lin J, Yang H, Kong W, He L, Ma X, Coppola D, Cheng JQ,. MicroRNA-221/222 negatively regulates estrogen receptor alpha and is associated with tamoxifen resistance in breast cancer. J Biol Chem 2008; 283: 31079-86.
27. Shen J, Ambrosone CB, DiCioccio RA, Odunsi K, Lele SB, Zhao H,. A functional polymorphism in the miR-146a gene and age of familial breast/ovarian cancer diagnosis. Carcinogenesis 2008; 29: 1963-6.
28. Taganov KD, Boldin MP, Chang KJ, Baltimore D,. NF-kappaB-dependent induction of microRNA miR-146, an inhibitor targeted to signaling proteins of innate immune responses. Proc Natl Acad Sci USA 2006; 103: 12481-6.
29. Yamashita M, Fatyol K, Jin C, Wang X, Liu Z, Zhang YE,. TRAF6 mediates Smad-independent activation of JNK and p38 by TGF-beta. Mol Cell 2008; 31: 918-24.
30. Fabbri M, Garzon R, Cimmino A, Liu Z, Zanesi N, Callegari E, Liu S, Alder H, Costinean S, Fernandez-Cymering C, Volinia S, Guler G, et al. MicroRNA-29 family reverts aberrant methylation in lung cancer by targeting DNA methyltransferases 3A and 3B. Proc Natl Acad Sci USA 2007; 104: 15805-10.
31. Klein ME, Lioy DT, Ma L, Impey S, Mandel G, Goodman RH,. Homeostatic regulation of MeCP2 expression by a CREB-induced microRNA. Nat Neurosci 2007; 10: 1513-14.
32. Koturbash I, Boyko A, Rodriguez-Juarez R, McDonald RJ, Tryndyak VP, Kovalchuk I, Pogribny IP, Kovalchuk O,. Role of epigenetic effectors in maintenance of the long-term persistent bystander effect in spleen in vivo. Carcinogenesis 2007; 28: 1831-8.
33. Gregory PA, Bert AG, Paterson EL, Barry SC, Tsykin A, Farshid G, Vadas MA, Khew-Goodall Y, Goodall GJ,. The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1. Nat Cell Biol 2008; 10: 593-601.
34. Paterson EL, Kolesnikoff N, Gregory PA, Bert AG, Khew-Goodall Y, Goodall GJ,. The microRNA-200 family regulates epithelial to mesenchymal transition. Sci World J 2008; 8: 901-4.
35. Peinado H, Olmeda D, Cano A,. Snail. Zeb and b. HLH factors in tumour progression: an alliance against the epithelial phenotype? Nat Rev 2007; 7: 415-28.
36. Agiostratidou G, Hulit J, Phillips GR, Hazan RB,. Differential cadherin expression: potential markers for epithelial to mesenchymal transformation during tumor progression. J Mammary Gland Biol Neoplasia 2007; 12: 127-33.
37. Aigner K, Dampier B, Descovich L, Mikula M, Sultan A, Schreiber M, Mikulits W, Brabletz T, Strand D, Obrist P, Sommergruber W, Schweifer N, et al. The transcription factor ZEB1 (deltaEF1) promotes tumour cell dedifferentiation by repressing master regulators of epithelial polarity. Oncogene 2007; 26: 6979-88.
38. Aigner K, Descovich L, Mikula M, Sultan A, Dampier B, Bonne S, van Roy F, Mikulits W, Schreiber M, Brabletz T, Sommergruber W, Schweifer N, et al. The transcription factor ZEB1 (deltaEF1) represses Plakophilin 3 during human cancer progression. FEBS Lett 2007; 581: 1617-24.
39. Eger A, Aigner K, Sonderegger S, Dampier B, Oehler S, Schreiber M, Berx G, Cano A, Beug H, Foisner R,. DeltaEF1 is a transcriptional repressor of E-cadherin and regulates epithelial plasticity in breast cancer cells. Oncogene 2005; 24: 2375-85.
40. Pauwels EK, Erba P, Mariani G, Gomes CM,. Multidrug resistance in cancer: its mechanism and its modulation. Drug News Perspect 2007; 20: 371-7.
41. Borst P, Evers R, Kool M, Wijnholds J,. A family of drug transporters: the multidrug resistance-associated proteins. J Natl Cancer Inst 2000; 92: 1295-302.
42. Negoro K, Yamano Y, Fushimi K, Saito K, Nakatani K, Shiiba M, Yokoe H, Bukawa H, Uzawa K, Wada T, Tanzawa H, Fujita S,. Establishment and characterization of a cisplatin-resistant cell line. KB-R, derived from oral carcinoma cell line KB. Int J Oncol 2007; 30: 1325-32.
43. Griffiths-Jones S, Saini HK, van Dongen S, Enright AJ,. miRBase: tools for microRNA genomics. Nucleic Acids Res 2008; 36: D154-D158.
44. Megraw M, Sethupathy P, Corda B, Hatzigeorgiou AG,. miRGen: a database for the study of animal microRNA genomic organization and function. Nucleic Acids Res 2007; 35: D149-D155.